Emerging evidence and recent advances Evidence continues to emerge regarding additional indications and benefits of GLP-1 medications, including effects on aging, dementia, Parkinsonism, wound healing, knee arthritis pain, auto-immune conditions, substance use, cancer prevention, and cardiac health
Minor variations in composition, including those related to characteristics such as colour or fragrance, may not always be reflected online
Suspected pancreatitis or gallstone-related pain particularly severe pain radiating to the back requires urgent medical attention
Currax Pharmaceuticals Recent Industry Developments in Anti-obesity Drugs Market January 2026: Novo Nordisk introduced Wegovy pill, the first oral GLP-1 approved for chronic weight management, across U.S
Endocrine regulation of gut function a role for glucagon-like peptide-1 in the pathophysiology of irritable bowel syndrome